152 related articles for article (PubMed ID: 32504836)
1. LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9.
Zhao LJ; Fan QQ; Li YY; Ren HM; Zhang T; Liu S; Maa M; Zheng YC; Liu HM
Pharmacol Res; 2020 Sep; 159():104991. PubMed ID: 32504836
[TBL] [Abstract][Full Text] [Related]
2. TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer.
Liu Q; Xiong J; Xu D; Hao N; Zhang Y; Sang Y; Wang Z; Zheng X; Min J; Diao H; Raphael J; Maleki Vareki S; Koropatnick J; Min W
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008676
[TBL] [Abstract][Full Text] [Related]
3. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
[TBL] [Abstract][Full Text] [Related]
4. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
[TBL] [Abstract][Full Text] [Related]
5. LINC00319 acts as a
Zou J; Wu K; Lin C; Jie ZG
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G10-G22. PubMed ID: 31433213
[TBL] [Abstract][Full Text] [Related]
6. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
8. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
[TBL] [Abstract][Full Text] [Related]
9. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
Song J; Liu Y; Wang T; Li B; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.
Cai M; Chen Q; Shen J; Lv C; Cai L
J Cell Mol Med; 2018 Oct; 22(10):4721-4731. PubMed ID: 30117667
[TBL] [Abstract][Full Text] [Related]
11. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
Hsu KW; Fang WL; Huang KH; Huang TT; Lee HC; Hsieh RH; Chi CW; Yeh TS
Oncotarget; 2016 Jun; 7(25):38036-38051. PubMed ID: 27191259
[TBL] [Abstract][Full Text] [Related]
12. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
[TBL] [Abstract][Full Text] [Related]
13. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
Zhang X; Zhang X; Yu B; Hu R; Hao L
Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
[TBL] [Abstract][Full Text] [Related]
14. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.
Zhu M; Wang M; Yang F; Tian Y; Cai J; Yang H; Fu H; Mao F; Zhu W; Qian H; Xu W
Oncotarget; 2016 Mar; 7(13):16567-80. PubMed ID: 26934326
[TBL] [Abstract][Full Text] [Related]
15. Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kwak C; Kim HH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847068
[TBL] [Abstract][Full Text] [Related]
16. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
18. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
19. LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression.
Chen M; Fan L; Zhang SM; Li Y; Chen P; Peng X; Liu DB; Ma C; Zhang WJ; Zou ZW; Li PD
Cell Death Dis; 2019 Jan; 10(2):70. PubMed ID: 30683847
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4.
Yu T; Wang LN; Li W; Zuo QF; Li MM; Zou QM; Xiao B
Cancer Sci; 2018 May; 109(5):1393-1403. PubMed ID: 29569792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]